These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1347 related articles for article (PubMed ID: 12001115)
1. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival. Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115 [TBL] [Abstract][Full Text] [Related]
2. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma. Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492 [TBL] [Abstract][Full Text] [Related]
4. Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness. Sengupta S; Lohse CM; Leibovich BC; Frank I; Thompson RH; Webster WS; Zincke H; Blute ML; Cheville JC; Kwon ED Cancer; 2005 Aug; 104(3):511-20. PubMed ID: 15973740 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of ploidy and proliferation markers in renal cell carcinoma. Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW Cancer; 1996 Jan; 77(1):164-71. PubMed ID: 8630925 [TBL] [Abstract][Full Text] [Related]
6. Kidney size and cancer-specific survival for patients undergoing nephrectomy for pT1 clear cell renal cell carcinoma. Jorns JJ; Thiel DD; Lohse C; Williams A; Arnold M; Cheville J; Leibovich B; Parker AS Urology; 2012 Jul; 80(1):147-50. PubMed ID: 22748870 [TBL] [Abstract][Full Text] [Related]
7. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers. Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma. Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379 [TBL] [Abstract][Full Text] [Related]
9. Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other. Tollefson MK; Thompson RH; Sheinin Y; Lohse CM; Cheville JC; Leibovich BC; Kwon ED Cancer; 2007 Aug; 110(4):783-90. PubMed ID: 17594714 [TBL] [Abstract][Full Text] [Related]
10. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy. Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571 [TBL] [Abstract][Full Text] [Related]
11. Limited prognostic value of tumor necrosis in patients with renal cell carcinoma. Isbarn H; Patard JJ; Lughezzani G; Rioux-Leclercq N; Crépel M; Cindolo L; de la Taille A; Zini L; Villers A; Shariat SF; Bertini R; Karakiewicz PI Urology; 2010 Jun; 75(6):1378-84. PubMed ID: 19781745 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma. Yoo C; Song C; Hong JH; Kim CS; Ahn H J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101 [TBL] [Abstract][Full Text] [Related]
13. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Leibovich BC; Blute ML; Cheville JC; Lohse CM; Frank I; Kwon ED; Weaver AL; Parker AS; Zincke H Cancer; 2003 Apr; 97(7):1663-71. PubMed ID: 12655523 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of ploidy, MIB-1 proliferation marker, and p53 in renal cell carcinoma. Kramer BA; Gao X; Davis M; Hall M; Holzbeierlein J; Tawfik O J Am Coll Surg; 2005 Oct; 201(4):565-70. PubMed ID: 16183495 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma. Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951 [TBL] [Abstract][Full Text] [Related]
17. Microscopic venous invasion in renal cell carcinoma as a predictor of recurrence after radical surgery. Ishimura T; Sakai I; Hara I; Eto H; Miyake H Int J Urol; 2004 May; 11(5):264-8. PubMed ID: 15147540 [TBL] [Abstract][Full Text] [Related]
18. Redefining pT3 renal cell carcinoma in the modern era: a proposal for a revision of the current TNM primary tumor classification system. Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG Cancer; 2007 Jun; 109(12):2439-44. PubMed ID: 17487856 [TBL] [Abstract][Full Text] [Related]
19. The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival. Zubac DP; Bostad L; Kihl B; Seidal T; Wentzel-Larsen T; Haukaas SA J Urol; 2009 Nov; 182(5):2144-9. PubMed ID: 19758660 [TBL] [Abstract][Full Text] [Related]
20. Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma. Jung EJ; Lee HJ; Kwak C; Ku JH; Moon KC Urology; 2009 Jan; 73(1):137-41. PubMed ID: 18950844 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]